Teva issued a nationwide recall this week affecting all of its generic Amlodipine/Valsartan combination tablets and Amlodipine/Valsartan/Hydrochlorothiazide combination tablets due to the presence of NDEA.…
A valsartan class action lawsuit filed by a Texas man accuses several manufacturers of knowing the drugs might be contaminated years before recalls were announced.…
European health experts estimate that 1 in 5,000 long-term users of recalled valsartan drugs could develop cancer because of exposure to NDMA.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
The FDA is expanding a valsartan recall and warning that additional products may be recalled in the coming days over fears that the blood pressure medications are contaminated with a cancer-causing impurity.…
The FDA is warning consumers to be aware which valsartan hypertension drugs are being recalled due to cancer fears.…
The FDA has announced that it is joining 22 other countries in recalling many versions of generic Diovan (valsartan), which may contain cancer-causing impurities.…
The first status conference for kidney injury lawsuits filed in federal court against the makers of Nexium and similar heartburn drugs is scheduled for September 12.…
With a growing number of kidney injury lawsuits filed by former users of Nexium, Prilosec, Protonix and other proton pump inhibitors, a panel of federal judges has decided to centralize the litigation in the District of New Jersey for coordinated discovery and pretrial proceedings.…
Teva Pharmaceuticals is recalling several hundred bottles of generic Invega due to problems with the extended-release tablets dissolving properly, which could lead to underdosing.…
